与神经退行相关的氧化损伤通过选择性α-synuclein化在synucleinopathy病变中的神经退行
B I Giasson1, J E Duda, I V Murray
1Center for Neurodegenerative Disease Research and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
概括
化α-synuclein蛋白在帕金森病和相关疾病特征的大脑病变中积聚. 这一发现直接将氧化压力与这些神经退行性同核病变的进展联系起来.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物化学 生物化学
背景情况:
- 聚合的α-synuclein形成了神经退行性synucleinopathies中脑损伤的标志.
- 氧化应激与某些同核蛋白病变的发病有关.
研究的目的:
- 调查化α-synuclein在主要synucleinopathies中的存在和意义.
- 建立氧化/酸性损伤与疾病进展之间的直接联系.
主要方法:
- 使用了针对alpha-synuclein中酸铁残留物的抗体.
- 检查了患有帕金森病,勒维体痴呆症,勒维体变异阿尔茨海默病和多重系统缩的患者的大脑组织.
- 分析了不溶性蛋白质分数和包含物体.
主要成果:
- 在所有研究的同核蛋白病变中,在所有签名包含中,化α-synuclein的广泛,广泛的积累被证明.
- 确定的化α-synuclein构成了这些含有的主要丝状成分.
- 在受影响大脑区域的不溶性部分中发现了化α-synuclein.
结论:
- 选择性化α-synuclein是帕金森病和相关疾病的关键特征.
- 提供了直接证据,将氧化和酸性损伤与突核蛋白病变的发病和进展联系起来.
- 突出了化α-synuclein作为一个潜在的生物标志物和治疗目标.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


